miércoles, 23 de abril de 2025

Who Benefits from Adjuvant Immunotherapy in Melanoma? Insights From Biomarker Data Teresa Amaral, MD, PhD | April 23, 2025

https://www.medscape.com/viewarticle/who-benefits-adjuvant-immunotherapy-melanoma-insights-2025a1000935

No hay comentarios:

Publicar un comentario